Narrow search
Showing 1 - 10 of 89,410
Cover Image
Fair prices for medicines? : exploring competent authorities’ and public payers’ preferences on pharmaceutical policies
Vogler, Sabine - In: Empirica : journal of european economics 46 (2019) 3, pp. 443-469
Persistent link: https://www.econbiz.de/10012242289
Cover Image
Special FDA designations for drug development : orphan, fast track, accelerated approval, priority review, and breakthrough therapy
Michaeli, Daniel; Michaeli, Christoph T.; Albers, Sebastian - In: The European journal of health economics 25 (2024) 6, pp. 979-997
Persistent link: https://www.econbiz.de/10014633366
Cover Image
Impact of price control on pharmaceutical sector with reference to India
Kolte, Ashutosh; Mal, Hoshiar; Fulambrikar, Mugdha; … - In: International journal of intelligent enterprise 8 (2021) 1, pp. 90-104
Persistent link: https://www.econbiz.de/10012512495
Cover Image
The economic driven by politics as values : the example of pharmaceuticals in France
Smith, Andy - In: New political economy 22 (2017) 6, pp. 611-627
Persistent link: https://www.econbiz.de/10011742973
Cover Image
Pharmaceutical governance
Biehl, João - In: Global pharmaceuticals : ethics, markets, practices, (pp. 206-239). 2006
Persistent link: https://www.econbiz.de/10003415524
Cover Image
The determinants of access to health care and medicines in India
Srivastava, Divya; McGuire, Alistair - In: Applied economics 48 (2016) 16/18, pp. 1618-1632
Persistent link: https://www.econbiz.de/10011456704
Cover Image
India's road to independence in manufacturing active pharmaceutical ingredients : focus on essential medicines
Cherian, Jerin Jose; Rahi, Manju; Singh, Shubhra; … - In: Economies : open access journal 9 (2021) 2, pp. 1-18
Background: Active Pharmaceutical Ingredient (API) manufacturing is an important segment of the Indian pharma industry. India ranks third in terms of volume of medicines produced, and is a major global supplier of generic medicines. However, India depends heavily on the import of several raw...
Persistent link: https://www.econbiz.de/10012547902
Cover Image
Protection guarantee of public health in the functioning of the pharmaceutical market based in the theory of state interference in the economy
Podsiadlo, Piotr; Jachowicz, Michał - In: European research studies 23 (2020) 6, pp. 451-468
Persistent link: https://www.econbiz.de/10012510363
Cover Image
R&D and market size : who benefits from orphan drug legislation?
Gamba, Simona; Magazzini, Laura; Pertile, Paolo - In: Journal of health economics 80 (2021), pp. 1-22
Persistent link: https://www.econbiz.de/10013179155
Cover Image
The competitive dynamics of the generic drug manufacturing industry
Hoffman, Evan - In: Business economics : the journal of the National … 52 (2017) 1, pp. 68-75
Persistent link: https://www.econbiz.de/10012013562